Literature DB >> 24261365

Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.

Natasha E Wehrli1, Min Ju Kim, Brent W Matza, Jonathan Melamed, Samir S Taneja, Andrew B Rosenkrantz.   

Abstract

OBJECTIVE: The purpose of this article is to evaluate the utility of various morphologic and quantitative MRI features in differentiating central renal cell carcinoma (RCC) from renal pelvic urothelial carcinoma.
MATERIALS AND METHODS: Sixty patients (39 men and 21 women; mean [± SD] age, 65 ± 14 years; 48 with central RCC and 12 with renal pelvic urothelial carcinoma) who underwent MRI, including diffusion-weighted imaging (b values, 0, 400, and 800 s/mm(2)) and dynamic contrast-enhanced imaging, before histopathologic confirmation were included. Tumor T2 signal intensity and apparent diffusion coefficients (ADCs) were measured and normalized to muscle and CSF (hereafter referred to as normalized T2 signal and normalized ADC, respectively) and then were compared using receiver operating characteristic analysis. Also, two blinded radiologists independently assessed all tumors for various qualitative features, which were compared with the Fisher exact test and unpaired Student t test.
RESULTS: Urothelial carcinoma exhibited significantly lower normalized ADC than did RCC (p = 0.008), but no significant difference was seen in ADC or normalized T2 signal intensity (p = 0.247-0.773). Normalized ADC had the highest area under the curve (0.757); normalized ADC below an optimal threshold of 0.451 was associated with sensitivity of 83% and specificity of 71% for diagnosing urothelial carcinoma. Features that were significantly more prevalent in urothelial carcinoma included global impression of urothelial carcinoma, location centered within the collecting system, collecting system defect, extension to the ureteropelvic junction, preserved renal shape, absence of cystic or necrotic areas, absence of hemorrhage, homogeneous enhancement, and hypovascularity (all p < 0.033). Increased T1 signal intensity suggestive of hemorrhage was significantly more prevalent in RCC (p = 0.02). Interreader agreement for the subjective features ranged from 61.7% to 98.3%.
CONCLUSION: In addition to various qualitative MRI parameters, normalized ADC has utility in differentiating central RCC from renal pelvic urothelial carcinoma. Such differentiation may assist decisions regarding possible biopsy and treatment planning.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24261365     DOI: 10.2214/AJR.13.10673

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  [Oncological diseases and postoperative alterations of the bladder and urinary tract].

Authors:  M M Ong; P Riffel; J Budjan; C Bolenz; S O Schönberg; S Haneder
Journal:  Radiologe       Date:  2014-12       Impact factor: 0.635

Review 2.  Hereditary Renal Tumor Syndromes: Update on Diagnosis and Management.

Authors:  Sonia Gaur; Baris Turkbey; Peter Choyke
Journal:  Semin Ultrasound CT MR       Date:  2016-10-14       Impact factor: 1.875

3.  Diagnostic Utility of Diffusion-weighted Magnetic Resonance Imaging in Differentiating Small Solid Renal Tumors (≤ 4 cm) at 3.0T Magnetic Resonance Imaging.

Authors:  Han-Mei Zhang; Ying-Hua Wu; Qi Gan; Xiao Lyu; Xiang-Lan Zhu; Min Kuang; Rong-Bo Liu; Zi-Xing Huang; Fang Yuan; Xi-Jiao Liu; Bin Song
Journal:  Chin Med J (Engl)       Date:  2015-06-05       Impact factor: 2.628

4.  Dynamic Contrast-enhanced MRI in Renal Tumors: Common Subtype Differentiation using Pharmacokinetics.

Authors:  Hai-Yi Wang; Zi-Hua Su; Xiao Xu; Ning Huang; Zhi-Peng Sun; Ying-Wei Wang; Lu Li; Ai-Tao Guo; Xin Chen; Xin Ma; Lin Ma; Hui-Yi Ye
Journal:  Sci Rep       Date:  2017-06-08       Impact factor: 4.379

Review 5.  Magnetic Fields and Cancer: Epidemiology, Cellular Biology, and Theranostics.

Authors:  Massimo E Maffei
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.